Recruiting
Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.
NCT06692712
- Conditions
- Hereditary Spastic Paraplegia Type 50, Nervous System Diseases, Neurologic Manifestations, +4 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- Sant Joan de Deu Barcelona, Spain